Erythropoietin or darbepoetin for patients with cancer
625 results
1 - 100
Infections in immunosuppressed and cancer patients - Essentials
- Tuberculosis
- Diseases and drugs causing immunosuppression
- Pneumocystis jirovecii
- Fungal infections
- References
- Causes of infection in patients with cancer
- Fever in the immunosuppressed patient
- Infections in cancer patients without severe neutropenia
- Prevention of bacterial and fungal infections in neutropenic patients or patients who have received stem cell transplantation
- Prevention and treatment of infections in splenectomized patients
- Varicella (chickenpox) and herpes zoster
- Cytomegalovirus (CMV)
- Influenza and other respiratory viral infections
- Psychosocial support for patients with cancer
- Treatment of depression in cancer patients
- Erythropoietin or darbepoetin for patients with malignant disease
- Preventing oral candidiasis in cancer patients
- Treating oral candidiasis in cancer patients
- Parenteral anticoagulation in ambulatory patients with cancer
- Testing for cancer in patients with unprovoked venous thromboembolism
- Interventions to enhance return-to-work for cancer patients
- Voriconazole versus amphotericin B in cancer patients with neutropenia
- Oral anticoagulation for prolonging survival in patients with cancer
- Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer
- Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer
- Prevention of oral mucositis in patients receiving treatment for cancer
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
- Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
- Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer
- Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer
- Follow-up strategies for patients treated for non-metastatic colorectal cancer
- Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
- Empirical anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
- Routine versus selective antifungal administration for control of fungal infections in patients with cancer
- Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients
- Aciclovir and valaciclovir in the prevention and treatment of herpes simplex virus in patients being treated for cancer
- Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
- Anaemia of chronic disease (ACD)
- Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery
- Prevention of venous thromboembolism
- Lung cancers
- Screening and prevention of colorectal cancer
- Hereditary susceptibility to cancer
- Porphyrias
- Cancer of the liver and the biliary tract
- Oesophageal cancer
- Colorectal cancer
- Prostate cancer
- Gynaecological cancers
- Adjuvant chemotherapy in colorectal cancer
- Breast cancer
- Long-term adverse effects of antineoplastic agents
- Primary care follow-up of thyroid cancer after treatment